CPHA Canvax

"The following recommendations were developed to inform clinical trials of candidate COVID-19 vaccines to protect against infection, serious illness, and deaths caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The findings of these trials will be used to inform vaccine recommendations made by NACI and public health program decisions that will be made by Canadian jurisdictions once a COVID-19 vaccine or vaccines become available in Canada." - Research priorities for COVID-19 vaccines to support public health decisions


Web link

Research priorities for COVID-19 vaccines to support public health decisions

Related Resources

Bookmark

Implementation Tool

Link

Category

Vaccine Safety and Development,Research and Development,Vaccine Development,Monitoring and Surveillance,Outbreaks and Pandemics,COVID-19 Vaccine Safety and Development
Research and Development
Vaccine Development
Monitoring and Surveillance
Outbreaks and Pandemics
COVID-19

0 Comments

Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.

All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.